Table 2.

Leave-one-out sensitivity analysis for the effects of newer antidiabetics on endothelial function.

Study excluded	MD (95% CI)	p value	Heterogeneity (I2)
DPP-4 inhibitors
Ayaori et al. [31]	1.253 (0.242 to 2.265)	p = 0.015	87.7%, p < 0.001
Baltzis et al. [32]	0.866 (-0.205 to 1.936)	p = 0.113	88.6%, p < 0.001
Dell'Oro et al. [34]	0.658 (-0.365 to 1.682)	p = 0.207	87.8%, p < 0.001
Ida et al. [52]	0.897 (-0.151 to 1.945)	p = 0.095	88.5%, p < 0.001
Nakamura et al. [24]	0.858 (-0.226 to 1.943)	p = 0.121	88.6%, p < 0.001
Kim et al. [37]	0.962 (-0.066 to 1.990)	p = 0.067	88.3%, p < 0.001
Kitao et al. [38]	0.948 (-0.115 to 2.011)	p = 0.080	87.1%, p < 0.001
Kubota et al. [53]	0.832 (-0.329 to 1.993)	p = 0.160	88.6%, p < 0.001
Leung et al. [40]	0.566 (-0.130 to 1.261)	p = 0.111	68.6%, p < 0.001
Li et al. [41]	0.679 (-0.337 to 1.695)	p = 0.190	88.1%, p < 0.001
Nomoto et al. [42]	0.917 (-0.153 to 1.986)	p = 0.093	88.2%, p < 0.001
Shigiyama et al. [44]	0.813 (-0.262 to 1.888)	p = 0.138	88.6%, p < 0.001
Suzuki et al. [25]	0.798 (-0.261 to 1.858)	p = 0.140	88.6%, p < 0.001
Maruhashi et al. [23]	0.906 (-0.152 to 1.964)	p = 0.093	88.4%, p < 0.001
Widlansky et al. [47]	0.899 (-0.161 to 1.960)	p = 0.097	88.5%, p < 0.001
GLP-1 RA
Gurkan et al. [35]	2.435 (-1.177 to 6.047)	p = 0.186	91.2%, p < 0.001
Hopkins et al. [51]	3.275 (-0.132 to 6.682)	p = 0.060	89.2%, p < 0.001
Irace et al. [36]	1.141 (-1.194 to 3.476)	p = 0.338	80.2%, p = 0.001
Lambadiari et al. [39]	1.902 (-1.399 to 5.203)	p = 0.259	89.3%, p < 0.001
Nomoto et al. [42]	3.155 (-0.376 to 6.687)	p = 0.080	88.1%, p < 0.001

DPP-4: dipeptidyl peptidase-4 inhibitors; GLP-1 RA: glucagon-like peptide-1 receptor agonists.